Evaluation of WIRION™ EPS in Lower Extremities Arteries

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.

Also called NCT02780349

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 103 participants (enrolled count) (from the registry)
Sponsor
Gardia Medical (from the registry)
Registry
  • NCT NCT02780349
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02780349. Allocation not applicable; no masking; primary purpose treatment. Start 2016-05 (actual); primary completion 2017-08-30 (actual). Results posted on 2018-02-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Acronym
WISE-LE
Condition
Peripheral Arterial Disease (PAD)
Intervention (Device)
WIRION
Lead sponsor
Gardia Medical (class: industry)

Record details

Record id
cardio:ct-nct02780349
Content hash
f6d4d449994fe75ea4a1086ab9d64a8be166186d0f827cacecdb62486e0f0e54